H

Humanitas Research Hospital | Department Dermatology

Research site
(Unclaimed)
Location
VIa Alessandro Manzoni 56, Rozzano, Lombardia, Italy
Site insights

Top conditions

Critical Illness (5 trials)

Coronary Artery Disease (5 trials)

Hepatocellular Carcinoma (5 trials)

Carcinoma (4 trials)

Pancreatic Cancer (3 trials)

Top treatments

Ephedrine
Etilefrine Hydrochloride
Flagyl
PXT002331
Cefuroxime
magnesium oxide
Macrogol 4000
Meropenem
Levodopa
Metformin

Parent organization

This site is a part of Humanitas Research Hospital

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

6 of 68
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

The objective of study IOA-244-101 is to determine whether IOA-244 is safe and tolerable in cancer patients (Part A). In addition, the study will ass...

Active, not recruiting
Myelofibrosis
Solid Tumor, Adult
Drug: Avelumab Injection
Drug: Ruxolitinib

A Phase 3b research study to consolidate the data that ivosidenib is safe and effective in adult patients with previously treated, locally advanced,...

Enrolling
Cholangiocarcinoma
Drug: Ivosidenib Oral Tablet

The aim of the DYNAMITE study is to investigate the (a) acute procedural and (b) 9-month follow-up performance of DynamX Drug-Eluting Coronary Bioada...

Active, not recruiting
Coronary Artery Disease
Long Lesions Coronary Artery Disease
Device: DynamX Drug-Eluting Coronary Bioadaptor System

The purpose of this study is to evaluate the safety and performance of the Tendyne Mitral Valve System in the treatment of severe mitral regurgitatio...

Active, not recruiting
Mitral Valve Regurgitation
Device: Tendyne Mitral Valve System

Osteoarthritis (OA) is a degenerative joint disease characterised by chronic pain, degradation and loss of articular cartilage, osteophyte formation...

Enrolling
Osteoarthritis, Knee
Device: KIT BMAC AND at-SVF FIDIA

This study is a Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician...

Enrolling
Cholangiocarcinoma
Drug: Physician's Choice
Drug: Tinengotinib 10 mg

Trial sponsors

I

Istituto Clinico Humanitas (29 trials)

Abbott logo

Abbott (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems